These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23133953)

  • 21. [Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer].
    Usui N
    Gan To Kagaku Ryoho; 2010 May; 37(5):805. PubMed ID: 20524247
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacology of purine nucleoside analogues.
    Plunkett W; Gandhi V
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy.
    Pinedo HM; Giaccone G
    Lancet; 1997 May; 349 Suppl 2():SII7-9. PubMed ID: 9164439
    [No Abstract]   [Full Text] [Related]  

  • 24. The intensive care support of patients with malignancy: do everything that can be done.
    Azoulay E; Afessa B
    Intensive Care Med; 2006 Jan; 32(1):3-5. PubMed ID: 16308682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy in elderly patients with hematological malignancies].
    Ohnishi K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1586-90. PubMed ID: 21996952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
    Fernández A; De Arriba F; Rivera J; Heras I; Vicente V; Lozano ML
    Haematologica; 2008 Sep; 93(9):1436-8. PubMed ID: 18641021
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chinese herbal drugs: sheng-bai-kuai in the treatment of leukopenia caused by chemotherapy].
    Tan D; Xie ZZ; Zhong M; Wu D; Liang X; Li W; Qin Q; Tam G
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):547-9. PubMed ID: 10073005
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies.
    Papaevangelou V; Varsami M; Papadakis V; Zellos A; Parcharidou A; Papargyri S; Karentzou O; Manolaki N; Roma E; Polychronopoulou S
    Pediatr Infect Dis J; 2010 Mar; 29(3):277-80. PubMed ID: 19949358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chemotherapy on plasma lipids and lipoproteins in Nigerian patients with haematological malignancy.
    Idogun SE; Omoti CE
    Niger Postgrad Med J; 2011 Mar; 18(1):16-9. PubMed ID: 21445108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New advances in the treatment of hematologic malignancies: focus on topoisomerase I inhibitors. Introduction.
    Kantarjian H
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):1-2. PubMed ID: 9779875
    [No Abstract]   [Full Text] [Related]  

  • 31. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
    Kami M; Hori A; Takaue Y; Mutou Y
    Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Advances of targeted therapy in treatment of hematologic malignancies].
    Huang H; Cao WJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):313-8. PubMed ID: 17717819
    [No Abstract]   [Full Text] [Related]  

  • 33. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
    Nani FK; Oğuztöreli MN
    IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drug development.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):556. PubMed ID: 20020666
    [No Abstract]   [Full Text] [Related]  

  • 35. Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
    el-Sayed MH; Shanab G; Karim AM; el-Tawil A; Black A; Dixon JS
    Pediatr Hematol Oncol; 2004 Mar; 21(2):145-56. PubMed ID: 15160513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bendamustine: a novel cytotoxic agent for hematologic malignancies.
    Blumel S; Goodrich A; Martin C; Dang NH
    Clin J Oncol Nurs; 2008 Oct; 12(5):799-806. PubMed ID: 18842536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?].
    Rukavitsyn OA; Pop VP
    Ter Arkh; 2008; 80(7):80-4. PubMed ID: 18763606
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemotherapy of hematological malignancies based on EBM].
    Ueda R
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():147-53. PubMed ID: 11989255
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 40. [Asparagus in asparaginase therapy?].
    März W; Unger C
    Med Monatsschr Pharm; 1999 Dec; 22(12):393. PubMed ID: 10628150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.